Curvebeam Ai logo
CVB
Health Care Equipment & Services

Curvebeam Ai

Short interest
0.00%
−0.06 pp 30d
as of 1 June 2026
Reported shorts
2K
Shares on issue
477.734M

Curvebeam Ai (CVB) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$8.7M (source: ASX (Markit))vs $12.1M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 14 Oct 2026
NPAT
−$18.8M (source: ASX (Markit))vs −$16.8M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 14 Oct 2026
EPS (diluted)
−$0.042 (source: Derived: trailing 12 months at year end)vs −$0.045 (FY25)
Derived: trailing 12 months at year end, as at 14 Oct 2026
Rev YoY
−28.4%FY
EPS YoY
n/aFY
  • ASX (Markit)
  • Derived: trailing 12 months at year end

Summary of Annual Report to shareholders - FY2026, 31 Aug 2026

CurveBeam AI reported revenue of $8.67 million for FY2026, down 28% from $12.10 million in FY2025, and a net loss of $18.83 million, widening 12% from the prior year's $16.84 million loss. No dividend was paid or declared. The company is focused on advancing its China partnership and robotic surgery integrations, with no formal revenue guidance provided.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026

Gross margin
n/a
Operating margin
n/a
Net margin
−217.3%
FCF margin
n/a
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
n/a
Cash dividends paid / net profit
n/a
Market cap
n/a (no share count we can vouch for)
P/E
n/a
P/B
n/a (no share count we can vouch for)

Ratios use the reporting currency (AUD); market cap is in AUD. Source: ASX (Markit), as at 14 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

CVB income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$8.7M (source: ASX (Markit))$12.1M (source: ASX (Markit))$6.5M$8.1M
Gross profitn/an/a$3.0M$4.4M
Operating incomen/an/a−$23.9M−$18.8M
EBITDAn/an/a−$18.6M−$43.5M
EBITn/an/a−$21.5M−$45.5M
Interest expensen/an/a$1.6M$5.7M
Pretax incomen/an/a−$23.1M−$51.2M
Taxn/an/a$0$0
NPAT−$18.8M (source: ASX (Markit))−$16.8M (source: ASX (Markit))−$23.1M−$51.2M
Net interest incomen/an/a−$1.3M−$5.7M
EPS basic−$0.042 (source: Derived: trailing 12 months at year end)−$0.045−$0.078−$0.85
EPS diluted−$0.042 (source: Derived: trailing 12 months at year end)−$0.045−$0.078−$0.85
Sharesn/an/a328.8M69.5M
  • ASX (Markit)
  • Derived: trailing 12 months at year end